Paper8008166
Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms.
Montine TJ and 6 others. Neurosurgery, 1994. Cited by 108 papers, by iCite.
Cite this record
ConductScience Library. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Papers, record 8008166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8008166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Astrocytoma | Major topic |
| Biomarkers, Tumor | Major topic |
| Cell Division | Major topic |
| Glioblastoma | Major topic |
| Neoplasm Proteins | Major topic |
| Nuclear Proteins | Major topic |
| Supratentorial Neoplasms | Major topic |
| Adult | |
| Aged | |
| Brain | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Ki-67 Antigen | |
| Male | |
| Middle Aged | |
| Survival Rate |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| T32 NS07304 | NINDS NIH HHS | United States | T32NS007304 | PubMed and NIH |
Source NIH RePORTER
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33654394 | Interleukin-1β-Treated Mesenchymal Stem Cells Inhibit Inflammation in Hippocampal Astrocytes Through Exosome-Activated Nrf-2 Signaling. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/33654394 | PubMed |
| 32964396 | Clinical Evaluation of Proline, Glutamic acid, and Leucine-Rich Protein 1 Expression in Astrocytomas and Correlations with the Proliferation Marker Ki-67. | J Mol Neurosci | 2021 | https://conductscience.org/library/papers/32964396 | PubMed |
| 30459861 | P53 and Ki-67 Expression in Primary Pediatric Brain Tumors: Does it Correlate with Presentation, Histological Grade, and Outcome? | Asian J Neurosurg | 2018 | https://conductscience.org/library/papers/30459861 | PubMed |
| 29487691 | T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma. | Oncotarget | 2018 | https://conductscience.org/library/papers/29487691 | PubMed |
| 28887715 | Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. | Brain Tumor Pathol | 2018 | https://conductscience.org/library/papers/28887715 | PubMed |
| 26984877 | A retrospective observational study on the treatment outcomes of 26 patients with spinal cord astrocytoma including two cases of malignant transformation. | Eur Spine J | 2016 | https://conductscience.org/library/papers/26984877 | PubMed |
| 23946790 | Expression of p53, epidermal growth factor receptor, Ki-67 and O6-methylguanine-DNA methyltransferase in human gliomas. | Oncol Lett | 2013 | https://conductscience.org/library/papers/23946790 | PubMed |
| 23902708 | Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors. | Diagn Pathol | 2013 | https://conductscience.org/library/papers/23902708 | PubMed |
| 19229057 | Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. | Neuro Oncol | 2009 | https://conductscience.org/library/papers/19229057 | PubMed |
| 16696004 | Comparison of different Ki67 antibodies in human glioblastomas. | Clin Mol Pathol | 1995 | https://conductscience.org/library/papers/16696004 | PubMed |
| 16234986 | Role of MIB1 in predicting survival in patients with glioblastomas. | J Neurooncol | 2006 | https://conductscience.org/library/papers/16234986 | PubMed |
| 16078103 | Techniques to assess the proliferative potential of brain tumors. | J Neurooncol | 2005 | https://conductscience.org/library/papers/16078103 | PubMed |
| 12187957 | Immunohistochemical markers for prognosis of cerebral glioblastomas. | J Neurooncol | 2002 | https://conductscience.org/library/papers/12187957 | PubMed |
| 12187956 | Immunohistochemical markers for prognosis of anaplastic astrocytomas. | J Neurooncol | 2002 | https://conductscience.org/library/papers/12187956 | PubMed |
| 12164686 | Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas. | J Neurooncol | 2002 | https://conductscience.org/library/papers/12164686 | PubMed |
| 11995813 | Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas. | J Neurooncol | 2002 | https://conductscience.org/library/papers/11995813 | PubMed |
| 11882906 | Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors. | Pathol Oncol Res | 2001 | https://conductscience.org/library/papers/11882906 | PubMed |
| 11859975 | The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature. | J Neurooncol | 2001 | https://conductscience.org/library/papers/11859975 | PubMed |
| 10778726 | Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression. | J Neurooncol | 1999 | https://conductscience.org/library/papers/10778726 | PubMed |
| 10645226 | Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. | J Clin Pathol | 1999 | https://conductscience.org/library/papers/10645226 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8008166
GET https://conductscience.org/api/papers/v1/8008166/cited_by?page=2